TCL Archive In Brief: NCHSR Says Autologous Marrow Transplant Is A “Reasonable Therapeutic Alternative” August 11, 1989
TCL Archive Patient Advocacy: NBCC Urges Funding For Treatment Of Women Screened In CDC Program July 17, 1998
TCL Archive Appropriations Committees Lean Toward Adding Some To NCI Budget; ACS To Ask Again For $1.5 Billion April 20, 1984
TCL Archive Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis December 27, 2013
TCL Archive Bristol Stock Drops Amid New Setbacks, Deepening Firm’s Decline In Oncology April 5, 2002
TCL Archive AACR Says 5 Percent Of Meeting Registrants Couldn’t Attend Due To Volcanic Ash In Europe April 30, 2010
